Nasopharyngeal carcinoma: past, present and future directions Zahra Taheri-Kadkhoda
Errata
Page Location Reads Should read
15 Main frame, Para 1, Line 10 …on focus… …the focus of attention…
16 Main frame, Para 2, Line 9 …those received RT... …those who received RT…
33 Main frame, Para 2, Line 7 …obstacles that may present…
…obstacles that may present themselves…
37-42 Main frame Paper I and IV Papers I and IV
38 Main frame, Para 1, Line 11 …recommended. …recommended for NPC.
48-54 Main frame Paper II and III Papers II and III 54 Main frame, Table 8, Lines
3, 4, 5, 6, and 8
… (77) …(76, 77)
59 Main frame, Para 3, Line 11 …in paper I and II… …in papers I and II…
65 Main frame, Para 2, Line 2 …tumour (III-IV) stages... …disease (III-IV) stages…
16 Paper III, Para 1, Line 16 …optimisazion… …optimization…
1-34 Paper IV tumor stage disease stage
1-34 Paper IV Late membrane protein 1 Latent membrane protein 1 4 Paper IV, Para 4, Line 3 were selected… were identified…
11 Paper IV, Para 1, Line 10 …with MLI < 70… …with MLI ≤ 170…
16 Paper IV, Para 1, Line 10 …MLI scores (> 70 versus
≤ 170)…
…MLI scores (> 170 versus
≤ 170)
